Your browser doesn't support javascript.
loading
Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli Infections.
Chorro, Laurent; Li, Zhenghui; Chu, Ling; Singh, Suddham; Gu, Jianxin; Kim, Jin-Hwan; Dutta, Kaushik; Pan, Rosalind; Kodali, Srinivas; Ndreu, Duston; Patel, Axay; Hawkins, Julio C; Ponce, Chris; Silmon de Monerri, Natalie; Keeney, David; Illenberger, Arthur; Jones, C Hal; Andrew, Lubomira; Lotvin, Jason; Prasad, A Krishna; Kanevsky, Isis; Jansen, Kathrin U; Anderson, Annaliesa S; Donald, Robert G K.
Afiliación
  • Chorro L; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Li Z; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Chu L; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Singh S; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Gu J; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Kim JH; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Dutta K; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Pan R; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Kodali S; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Ndreu D; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Patel A; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Hawkins JC; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Ponce C; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Silmon de Monerri N; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Keeney D; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Illenberger A; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Jones CH; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Andrew L; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Lotvin J; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Prasad AK; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Kanevsky I; Citranvi Biosciences, Chapel Hill, North Carolina, USA.
  • Jansen KU; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Anderson AS; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
  • Donald RGK; Pfizer Vaccine Research and Development, Pearl River, New York, USA.
Infect Immun ; 90(4): e0002222, 2022 04 21.
Article en En | MEDLINE | ID: mdl-35311580
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos O / Infecciones por Escherichia coli Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Infect Immun Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos O / Infecciones por Escherichia coli Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Infect Immun Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos